Patient Access Growth RareMed Solutions specializes in concierge-level patient access for complex therapies, presenting a sales opportunity to expand partnerships with biopharma companies seeking improved patient enrollment, adherence, and outcomes for high-touch treatments.

Awards Momentum Multiple recent accolades and finalist status in MMIT Patient Choice Awards and Pittsburgh Fast 50 highlight strong market credibility and performance, providing talking points to secure new contracts with health systems and pharma partners seeking proven service providers.

Strategic Partnerships Expansion of non-commercial dispensing services for PTC Therapeutics demonstrates a capability to scale specialized programs; this suggests potential cross-sell with other specialty therapies requiring patient support infrastructure.

Growth and Scale Revenue in the low hundreds of millions and sustained consecutive finalist recognition indicate operational maturity; sales teams can position RareMed as a scalable, reliable partner for mid-to-large pharma clients aiming for broad patient access initiatives.

Healthcare Innovation Strong tech stack and patient-centric service model align with digital health and data-driven patient support trends, presenting opportunities to offer integrated tech-enabled solutions to optimize patient onboarding, monitoring, and satisfaction metrics.